Skip to main content
High RiskFDAfda-F-0085-2015UNDECLARED ALLERGEN

Cases of refrigerated Pillsbury Biscuits Buttermilk 4pk. (6 - 4pk / case)

Category
Units Affected
720
Recall Date
September 26, 2014
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0085-2015.

Undeclared Milk ingredient on retail package. In error, individually wrapped packages of Pillsbury Biscuits Buttermilk were placed into Pillsbury Biscuit Flaky layers overwrap to make the 4pk. The individual packages of the product are labeled correctly however the overwrap is not the correct product.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0085-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact General Mills, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0085-2015.

General Mills, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

General Mills, Inc. Recall FAQ

General Mills, Inc. is the subject of a dairy safety report: Cases of refrigerated Pillsbury Biscuits Buttermilk 4pk. (6 - 4pk / case). The notice was published on September 26, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 720 units are potentially affected.